Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PrecisionMed is a provider of human biospecimens for research under BioIVT, rather than a typical SaaS or enterprise software product. Its website focuses on its biobank capabilities, covering CSF, serum, plasma, urine, tissue, FFPE, liquid biopsy, oncology, neuroscience samples, and more. Its target users include pharmaceutical companies, biotechnology firms, academic institutions, and government research organizations.
Its most notable resource is human cerebrospinal fluid, or CSF. The site describes it as the world’s largest commercial CSF biobank, offering both disease samples and TruNormal® normal controls. Samples can be collected longitudinally and come with clinical annotation data such as diagnosis, demographics, family history, treatment response, and disease progression. Its workflow includes clinical site verification, standardized collection and quality control, collection of clinical and demographic data, optimal storage, ready-to-ship inventory, and customer ownership of the samples after purchase.
The website does not publish packages or pricing, nor does it provide software subscription information. Inventory and quotes are mainly obtained via “Request Inventory.” The site states that inventory is available for immediate supply and can be shipped within 3 days. Payment methods, contract terms, international shipping costs, cold-chain requirements, and related details are not disclosed.
On compliance, the site explicitly states that samples are collected under US IRB-approved clinical protocols and says its biobank meets regulatory requirements. Its samples have been cited in 120+ scientific journals, used by 600+ customers, and applied in NIH-funded projects as well as research related to FDA diagnostic submissions/approvals. This information is useful for life sciences procurement teams.
The main advantages are its scarce CSF resources, relatively complete sample annotations, clear quality-control processes, strong ready-inventory capability, and the promise that customers receive 100% ownership rights to purchased samples. The drawbacks are limited transparency around pricing, payments, cross-border logistics, and local support in China. From a SaaS perspective, it also lacks software capabilities such as team permissions, APIs, third-party integrations, and cloud deployment. It is suitable for pharmaceutical companies, IVD teams, liquid biopsy researchers, neuroscience groups, and biomarker research teams, but it is not appropriate to evaluate as an enterprise software purchase.
The site does not state the access situation from China, and payment and import compliance are also unclear. Domestic users should also pay attention to human sample import requirements, ethics approvals, cold-chain logistics, and data compliance. Comparable options include BioIVT, Discovery Life Sciences, and iSpecimen, or domestic compliant biobanks and hospital research collaboration channels.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on precisionmed.com official site.
precisionmed.com is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach precisionmed.com directly.